Synpromics is developing a strategic portfolio of valuable synthetic promoters for specific application across its target markets, such as cell & gene therapy, bio-manufacturing, and industrial & agricultural biotechnologies.
Synthetic promoters are DNA sequences that do not exist in nature and which are designed to regulate the activity of genes, controlling a gene’s ability to produce its own uniquely encoded protein. Currently, within the biotech industry, naturally occurring promoters are used to drive protein production.
|Employees (est.) (May 2019)||35|
Synpromics total Funding
Synpromics latest funding size
Time since last funding
|2 years ago|
|Calculus Capital, Scottish Investment Bank|
Synpromics has 663 Twitter Followers. The number of followers has increased 1.8% month over month and increased 4.9% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Synpromics founded?
Synpromics was founded in 2010.
Who are Synpromics key executives?
Synpromics's key executives are David Venables, Michael Roberts and Rosheen Caw.
How many employees does Synpromics have?
Synpromics has 35 employees.
Who are Synpromics competitors?
Competitors of Synpromics include Prenetics, Wave Life Sciences and eGenesis.
Where is Synpromics headquarters?
Synpromics headquarters is located at 9 Little France Rd, Edinburgh.
Where are Synpromics offices?
Synpromics has an office in Edinburgh.
How many offices does Synpromics have?
Synpromics has 1 office.